11.5% of XPH Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the SPDR S&P Pharmaceuticals ETF (XPH) shows an impressive 11.5% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Endo Health Solutions Inc (ENDP), which makes up 4.71% of the SPDR S&P Pharmaceuticals ETF (XPH), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here